Avalo Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 5.10 M | $94.25 M | 77.12% | 11.70% |
| BLACKROCK, INC. | 08/07/2026 | 4.37 M | $80.68 M | 1,234.70% | 10.01% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 3.61 M | $66.71 M | 100.00% | 8.28% |
| CALIGAN PARTNERS LP | 08/14/2026 | 3.16 M | $58.47 M | 93.51% | 7.26% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 3.02 M | $55.76 M | 308.61% | 6.92% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 2.90 M | $53.59 M | 116.28% | 6.65% |
| STATE STREET CORP | 09/22/2026 | 2.89 M | $53.39 M | 3,932.28% | 6.63% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2026 | 2.50 M | $46.16 M | 172.71% | 5.73% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2026 | 2.39 M | $44.11 M | 160.55% | 5.47% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2026 | 2.33 M | $43.12 M | 65.48% | 5.35% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.26 M | $41.84 M | 214.61% | 5.19% |
| BVF INC/IL | 08/14/2026 | 2.08 M | $38.36 M | 27.11% | 4.76% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.91 M | $35.37 M | 197.64% | 4.39% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 1.86 M | $34.41 M | 50.79% | 4.27% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 1.73 M | $31.95 M | 102.46% | 3.97% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 1.65 M | $30.58 M | 274.45% | 3.80% |
| BRAIDWELL LP | 08/14/2026 | 1.63 M | $30.11 M | 100.00% | 3.74% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.31 M | $24.24 M | 100.00% | 3.01% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 1.26 M | $23.30 M | 100.00% | 2.89% |
| UBS GROUP AG | 08/13/2026 | 1.21 M | $22.34 M | 5.87% | 2.77% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 1.15 M | $21.25 M | 283.33% | 2.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.11 M | $20.43 M | 550.49% | 2.53% |
| COMMODORE CAPITAL LP | 08/14/2026 | 1.02 M | $18.82 M | 110.83% | 2.34% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 1.00 M | $18.48 M | 50.84% | 2.29% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 946.32 K | $17.49 M | 1,474.42% | 2.17% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 891.88 K | $16.48 M | 100.00% | 2.05% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 891.41 K | $16.47 M | 417.81% | 2.04% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 861.71 K | $15.92 M | 17.79% | 1.98% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 775.00 K | $14.32 M | 100.00% | 1.78% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 770.77 K | $14.24 M | 260.48% | 1.77% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 766.29 K | $14.16 M | 100.00% | 1.76% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 702.05 K | $12.97 M | 116.51% | 1.61% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 589.25 K | $10.89 M | 624.91% | 1.35% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 550.00 K | $10.16 M | 100.00% | 1.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 500.40 K | $9.25 M | 100.00% | 1.15% |
| DAVERN CAPITAL PARTNERS, LP | 08/13/2026 | 468.67 K | $8.66 M | 100.00% | 1.07% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 434.03 K | $8.02 M | 46.67% | 1.00% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 404.19 K | $7.47 M | 100.00% | 0.93% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 375.00 K | $6.93 M | 25.00% | 0.86% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 357.20 K | $6.60 M | 197.38% | 0.82% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 344.80 K | $6.37 M | 100.00% | 0.79% |
| NORTHERN TRUST CORP | 08/13/2026 | 344.52 K | $6.37 M | 1,027.51% | 0.79% |
| DV EQUITIES, LLC | 08/14/2026 | 332.21 K | $6.14 M | 100.00% | 0.76% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 324.81 K | $6.00 M | 275.79% | 0.74% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 324.45 K | $6.00 M | 75.26% | 0.74% |
| CITADEL ADVISORS LLC | 09/02/2026 | 323.83 K | $5.98 M | 67.15% | 0.74% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 310.01 K | $5.73 M | 100.00% | 0.71% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 284.70 K | $5.26 M | 100.00% | 0.65% |
| VIVO CAPITAL, LLC | 08/14/2026 | 275.00 K | $5.08 M | 100.00% | 0.63% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 241.90 K | $4.47 M | -48.99% | 0.55% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avalo Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 168 institutional investors and hedge funds held shares of Avalo Therapeutics Inc. The most heavily invested institutionals were:
GAMMA Investing LLC: 189
Versant Capital Management, Inc: 51
CoreCap Advisors, LLC: 13
Farther Finance Advisors, LLC: 12
FMR LLC: 5.1 M
BlackRock, Inc.: 4.37 M
162.58% of Avalo Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 71.80 M shares in the last 24 months. This purchase volume represents approximately $1.24 B in transactions.